PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial
January 21, 2021 at 08:00 am EST
PolarityTE, Inc. announced it has completed target enrollment of 100 subjects in a randomized controlled trial (RCT) evaluating SkinTE® plus standard of care (SOC) versus SOC alone for the treatment of diabetic foot ulcers (DFUs). PolarityTE plans to report topline data via press release and presentation at the Symposium on Advanced Wound Care (SAWC) Spring 2021 to be held May 12-16, 2021, barring any unforeseen scheduling or other disruptions due to COVID-19. The primary endpoint of this Diabetic Foot Ulcer Trial (NCT03881254) is a comparison of the percent of index
ulcers closed at 12 weeks.